IP Library › Granted Patent US 10,543,295
Granted Patent B2
US 10,543,295 · App. 16/505,326 · Granted Jan 28, 2020

Particles

Inventors: Gregory M. Cruise (Rancho Santa Margarita, CA); Steve Plotkin (Aliso Viejo, CA); Xinping Wu (Aliso Viejo, CA)
Assignee: MicroVention, Inc.
A61L24/06A61L24/001C08F222/385A61L2430/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,543,295
App. No.
16/505,326
Granted
Jan 28, 2020
Kind
B2
Abstract

Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.

Claims (23)

1. A method of treating a vascular defect, the method comprising:

delivering particles to a vascular defect behind a porous material,

wherein the particles include a reaction product of a prepolymer solution including:

a poly(ethylene glycol) diacrylamide macromer, a poly(ethylene glycol) diacrylate macromer, a poly(ethylene glycol) dimethacrylate macromer, a poly(ethylene glycol) dimethacrylamide macromer, or a combination thereof; and

at least one monomer,

wherein the particles have a diameter greater than a maximum pore size of the porous material.

2. The method of claim 1 , wherein the particles are delivered using a microcatheter.

3. The method of claim 1 , the microcatheter is a 0.0165″ microcatheter.

4. The method of claim 1 , wherein the diameter is between about 50 μm and about 1,500 μm.

5. The method of claim 1 , wherein the diameter is between about 200 μm and about 500 μm.

6. The method of claim 4 , wherein the diameter expands to about 400 μm to about 1500 μm.

7. The method of claim 2 , wherein the porous material is on a stent.

8. The method of claim 7 , wherein the stent is deployed over the microcatheter.

9. The method of claim 1 , wherein the pore size is about 0.006″.

10. The method of claim 1 , wherein the pore size is at most about 0.09″.

11. The method of claim 1 , wherein the prepolymer solution further includes a crosslinker.

12. The method of claim 11 , wherein the crosslinker is biodegradable.

13. The method of claim 11 , wherein the crosslinker has a structure:

wherein each n is independently 1-20;

wherein d, e, f, and g are each independently 1-20; or

14. The method of claim 11 , wherein the particles further include a visualization agent having a structure:

15. The method of claim 1 , wherein the at least one monomer includes ionic groups.

16. The method of claim 15 , wherein the at least one monomer containing ionic groups is sodium acrylate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2019
From: CRUISE, GREGORY M.; PLOTKIN, STEVE; WU, XINPING
To: MICROVENTION, INC.
Reel/Frame 050092/0762 →
Continuity (5)
Continuation 16184862 · Nov 8, 2018
Continuation 15878294 · Jan 23, 2018
Continuation 15081648 · Mar 25, 2016
Provisional Application 62138859 · Mar 26, 2015
Related Publication 20190343982A1 · Nov 14, 2019
Cited By (2)
US 12,364,786 US 12,447,228